Dow Down 0.18% Nasdaq Up 0.39%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
12.20 Up 0.38(3.21%) 4:00PM EDT
Prev Close:11.82
Open:12.02
Bid:11.85 x 200
Ask:12.80 x 4800
1y Target Est:15.27
Beta:1.75
Earnings Date:Oct 23 - Oct 27 (Est.)
Day's Range:11.88 - 12.74
52wk Range:10.28 - 18.34
Volume:1,302,761
Avg Vol (3m):820,666
Market Cap:1.05B
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IMGNUp 3.21%1.05B
PFEDown 0.44%185.53B
RHHBYUp 0.14%248.42B
SGENDown 3.16%5.26B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.72
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback